4H-pyrano[3,4-c]quinolin-4-one

Details

Top
Internal ID 3b835ff7-8771-45fa-a93b-bf5f80d42390
Taxonomy Organoheterocyclic compounds > Quinolines and derivatives > Quinolones and derivatives > Pyranoquinolines
IUPAC Name pyrano[3,4-c]quinolin-4-one
SMILES (Canonical) C1=CC=C2C(=C1)C3=C(C=N2)C(=O)OC=C3
SMILES (Isomeric) C1=CC=C2C(=C1)C3=C(C=N2)C(=O)OC=C3
InChI InChI=1S/C12H7NO2/c14-12-10-7-13-11-4-2-1-3-9(11)8(10)5-6-15-12/h1-7H
InChI Key NOAIRJZXLSKGPM-UHFFFAOYSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C12H7NO2
Molecular Weight 197.19 g/mol
Exact Mass 197.047678466 g/mol
Topological Polar Surface Area (TPSA) 39.20 Ų
XlogP 2.20
Atomic LogP (AlogP) 2.34
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
Cherimoline[alkaloid]
CHEMBL4168010
NSC756042
NSC-756042
196958-70-0
InChI=1/C12H7NO2/c14-12-10-7-13-11-4-2-1-3-9(11)8(10)5-6-15-12/h1-7

2D Structure

Top
2D Structure of 4H-pyrano[3,4-c]quinolin-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9973 99.73%
Caco-2 + 0.7131 71.31%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.7286 72.86%
Subcellular localzation Mitochondria 0.5844 58.44%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9481 94.81%
OATP1B3 inhibitior + 0.9680 96.80%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.7622 76.22%
P-glycoprotein inhibitior - 0.9246 92.46%
P-glycoprotein substrate - 0.9663 96.63%
CYP3A4 substrate - 0.5553 55.53%
CYP2C9 substrate - 0.8300 83.00%
CYP2D6 substrate - 0.8612 86.12%
CYP3A4 inhibition - 0.9369 93.69%
CYP2C9 inhibition - 0.8624 86.24%
CYP2C19 inhibition - 0.7327 73.27%
CYP2D6 inhibition - 0.9407 94.07%
CYP1A2 inhibition + 0.8428 84.28%
CYP2C8 inhibition - 0.6036 60.36%
CYP inhibitory promiscuity - 0.9444 94.44%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.5828 58.28%
Eye corrosion - 0.9722 97.22%
Eye irritation + 0.5286 52.86%
Skin irritation + 0.6049 60.49%
Skin corrosion - 0.9688 96.88%
Ames mutagenesis + 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6433 64.33%
Micronuclear + 0.5900 59.00%
Hepatotoxicity + 0.8052 80.52%
skin sensitisation + 0.6534 65.34%
Respiratory toxicity + 0.5778 57.78%
Reproductive toxicity + 0.5111 51.11%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity + 0.4559 45.59%
Acute Oral Toxicity (c) III 0.7719 77.19%
Estrogen receptor binding + 0.7926 79.26%
Androgen receptor binding + 0.6763 67.63%
Thyroid receptor binding + 0.5413 54.13%
Glucocorticoid receptor binding + 0.8755 87.55%
Aromatase binding + 0.9156 91.56%
PPAR gamma + 0.7788 77.88%
Honey bee toxicity - 0.7885 78.85%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity - 0.5450 54.50%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 95.12% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.22% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.52% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 89.12% 89.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.80% 99.23%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.08% 94.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.43% 85.14%
CHEMBL5409 Q8TDU6 G-protein coupled bile acid receptor 1 85.97% 93.65%
CHEMBL3401 O75469 Pregnane X receptor 85.38% 94.73%
CHEMBL2535 P11166 Glucose transporter 85.11% 98.75%
CHEMBL1868 P17948 Vascular endothelial growth factor receptor 1 83.97% 96.47%
CHEMBL2095172 P14867 GABA-A receptor; alpha-1/beta-2/gamma-2 81.80% 92.67%
CHEMBL2581 P07339 Cathepsin D 81.05% 98.95%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.40% 86.33%

Cross-Links

Top
PubChem 638628
NPASS NPC189636
LOTUS LTS0171051
wikiData Q105182431